Skip Navigation

Livestream

Create free account

Philip Morris CEO: We're pleased with FDA approval of Zyn

In this video

PM

Philip Morris CEO: We're pleased with FDA approval of Zyn

Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.

05:57

Thu, Feb 6 202511:52 AM EST

House passes resolution to curb Pres. Trump's war powers in Iran

House passes resolution to curb Pres. Trump's war powers in Iran

an hour ago

Perpetual futures incite bad behavior, says CME CEO Terry Duffy

Perpetual futures incite bad behavior, says CME CEO Terry Duffy

an hour ago

President Trump talks status of ceasefire with Iran from the Oval Office

President Trump talks status of ceasefire with Iran from the Oval Office

an hour ago

SpaceX looking to price IPO at $135 per share, offering 555.6 million shares

SpaceX looking to price IPO at $135 per share, offering 555.6 million shares

2 hours ago

Goldman's John Waldron: Exuberance is a pretty good word to describe equity markets

Goldman's John Waldron: Exuberance is a pretty good word to describe equity markets

3 hours ago

House passes resolution to curb Pres. Trump's war powers in Iran

House passes resolution to curb Pres. Trump's war powers in Iran

an hour ago

Perpetual futures incite bad behavior, says CME CEO Terry Duffy

Perpetual futures incite bad behavior, says CME CEO Terry Duffy

an hour ago

President Trump talks status of ceasefire with Iran from the Oval Office

President Trump talks status of ceasefire with Iran from the Oval Office

an hour ago

SpaceX looking to price IPO at $135 per share, offering 555.6 million shares

SpaceX looking to price IPO at $135 per share, offering 555.6 million shares

2 hours ago

Goldman's John Waldron: Exuberance is a pretty good word to describe equity markets

Goldman's John Waldron: Exuberance is a pretty good word to describe equity markets

3 hours ago